Updated: May 19, 2026

Heek G Jan Van

NERVMinerva Neurosciences, Inc.SEC CIK: 0001021040
Estimated Net Worth
$28.6 Million
Last Updated: May 19, 2026 11:07 PM EST

Transaction Summary

Total Transactions58
Buy-Sell Ratio0.21
Buy Transactions3
Sell Transactions14

Transaction Volume

Total Volume-$28.39M
Net Volume$28.58M
Buy Volume$94.49K
Sell Volume-$28.49M

Trade Analysis

AVG Trade Size-$488.20K
Largest Trade$53.70K
Most Active MonthJun
Most Active Year2003

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Heek G Jan Van has an estimated net worth of $28.6 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, GENZYME CORP, Minerva Neurosciences, Inc., and VIACELL INC.



2003 was Heek G Jan Van's most active year for acquiring shares with 53 total transactions. Heek G Jan Van's most active month to acquire stocks was the month of September. 2003 was Heek G Jan Van's most active year for disposing of shares, totalling 102 transactions. Heek G Jan Van's most active month to dispose stocks was the month of September. 2003 saw Heek G Jan Van paying a total of $28,467,543.93 for 1,122,096 shares, this is the most they've acquired in one year. In 2003 Heek G Jan Van cashed out on 2,186,523 shares for a total of $53,224,003.22, their largest year based on trade value.

Holdings & Transactions

NERVminerva neurosciences, inc.
Updated: Dec 23, 2025VIEW QUOTE
Form TypeSEC Filing
50.00K50.00KDec 22View
12.50K12.50KDec 05View
12.50K12.50KSep 27View
2.50K2.50KJun 10View
20.00K20.00KJun 11View
0.537.00K$2.97$20.79K20.33KSep 10View
20.00K20.00KJun 11View
3.0010.00K$5.37$53.70K13.33KJun 26View
20.00K20.00KMay 31View
20.00K20.00KJun 07View
12.50K12.50KJun 01View
12.50K12.50KJun 16View
7.50K7.50KFeb 02View
55.30K$6.00$20.00K55.30KJun 30 - 01View
View
AMRNamarin corp plc\uk
Updated: Jun 29, 2022VIEW QUOTE
Form TypeSEC Filing
209.67K209.67KJun 27View
81.95K81.95KJun 14View
62.00K62.00KJul 13View
17.09K17.09KMay 20View
-0.93203.38K$12.24-$3.21M14.17KScheduledFeb 22View
78.13K78.13KMay 14View
35.85K35.85KMay 15View
49.40K49.40KJul 11View
99.00K99.00KJul 06View
52.50K52.50KMar 11View
1.0324.25K$5.59$9.81K47.70KJul 09 - 10View
0.061.33K$7.38$9.81K23.45KApr 10View
0.04948.00$8.37$7.93K22.12KJan 10View
0.03708.00$11.20$7.93K21.17KOct 10View
2.2945.55K$14.40$7.93K65.46KJul 10View
0.04848.00$9.35$7.93K19.91KApr 10View
0.05894.00$7.06$6.31K19.06KJan 10View
0.04666.00$9.47$6.31K18.17KOct 11View
0.03445.00$14.18$6.31K17.50KJul 11View
0.05742.00$8.50$6.31K17.06KApr 11View
-0.2230.00K$8.81-$466.48K106.32KApr 25View
-0.163.00K$1.03-$3.09K16.32KScheduledApr 18View
-0.023.00K$8.77-$46.44K136.32KScheduledApr 18View
0.04685.0019.32KFeb 09View
From 3/A18.63KView
14.04KView
viacell inc
Updated: Jun 01, 2007
Form TypeSEC Filing
15.00K15.00KMay 30View
15.00K15.00KMay 19View
10.00K10.00KJun 09View
875.00View
genzyme corp
Executive Vice President Officer
Updated: Jan 26, 2004
Form TypeSEC Filing
-0.66297.61K$38.87-$6.19M348.13KOct 17View
-0.3110.80K$46.80-$12.12K121.15KDec 17View
-0.66297.61K$38.87-$6.19M349.60KOct 17View
-0.61308.41K$39.09-$6.24M484.68KOct 17View
-0.8825.00K$26.84-$978.50K10.34KScheduledOct 01View
-0.4725.00K$27.26-$999.45K35.34KScheduledSep 02View
-0.4725.00K$27.26-$999.45K35.34KScheduledSep 02View
-0.3225.00K$28.66-$1.07M60.33KScheduledAug 01View
-0.4725.00K$27.26-$999.45K35.34KScheduledSep 02View
-0.3225.00K$28.66-$1.07M60.33KScheduledAug 01View
View
View
ScheduledView